Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Isenberg

Showing results (141-150 of 280) with videos related to

Pageof 28
Sort By:
Journal of Thrombosis and Haemostasis : JTH|June 30, 2023
Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid AntibodiesHannah Cohen, David J Werring, Arvind Chandratheva, et al.
The Journal of Biological Chemistry|May 14, 2011
p185, an immunodominant epitope, is an autoantigen mimotopeSanjeev Kumar, John A Hinks, Joseph Maman, et al.
Rheumatology (Oxford, England)|March 15, 2011
The efficacy of repeated treatment with B-cell depletion therapy in systemic lupus erythematosus: an evaluationTabitha Turner-Stokes, Tim Y Lu, Michael R Ehrenstein, et al.
Seminars in Arthritis and Rheumatism|March 7, 2003
A systematic analysis of sequences of human antiphospholipid and anti-beta2-glycoprotein I antibodies: the importance of somatic mutations and certain sequence motifsIan P Giles, Joanna D Haley, Sylvia Nagl, et al.
Rheumatology (Oxford, England)|April 28, 2022
Extent of vascular plaque predicts future cardiovascular events in patients with systemic lupus erythematosusJyoti Bakshi, Sara C Croca, Maura Griffin, et al.
Nature Reviews. Rheumatology|November 28, 2024
An update on autoantibodies in the idiopathic inflammatory myopathiesNur Azizah Allameen, Ana Isabel Ramos-Lisbona, Lucy R Wedderburn, et al.
The Journal of Experimental Medicine|July 29, 2004
Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapyMichael R Ehrenstein, Jamie G Evans, Animesh Singh, et al.
Annals of the Rheumatic Diseases|April 7, 2007
B cell depletion therapy in systemic lupus erythematosus: long-term follow-up and predictors of responseKristine P Ng, Geraldine Cambridge, Maria J Leandro, et al.
Rheumatology (Oxford, England)|March 11, 2009
Use of a strategy based on calculated risk scores in managing cardiovascular risk factors in a large British cohort of patients with systemic lupus erythematosusSean G O'Neill, Jose M Pego-Reigosa, Aroon D Hingorani, et al.
Molecular Immunology|December 23, 2003
Somatic mutations to arginine residues affect the binding of human monoclonal antibodies to DNA, histones, SmD and Ro antigenJoanna Haley, Lesley J Mason, Sylvia Nagl, et al.
Pageof 28

Showing results (141-150 of 280) with videos related to

Sort By:
Pageof 28
Journal of Thrombosis and Haemostasis : JTH|June 30, 2023
Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid AntibodiesHannah Cohen, David J Werring, Arvind Chandratheva, et al.
The Journal of Biological Chemistry|May 14, 2011
p185, an immunodominant epitope, is an autoantigen mimotopeSanjeev Kumar, John A Hinks, Joseph Maman, et al.
Rheumatology (Oxford, England)|March 15, 2011
The efficacy of repeated treatment with B-cell depletion therapy in systemic lupus erythematosus: an evaluationTabitha Turner-Stokes, Tim Y Lu, Michael R Ehrenstein, et al.
Seminars in Arthritis and Rheumatism|March 7, 2003
A systematic analysis of sequences of human antiphospholipid and anti-beta2-glycoprotein I antibodies: the importance of somatic mutations and certain sequence motifsIan P Giles, Joanna D Haley, Sylvia Nagl, et al.
Rheumatology (Oxford, England)|April 28, 2022
Extent of vascular plaque predicts future cardiovascular events in patients with systemic lupus erythematosusJyoti Bakshi, Sara C Croca, Maura Griffin, et al.
Nature Reviews. Rheumatology|November 28, 2024
An update on autoantibodies in the idiopathic inflammatory myopathiesNur Azizah Allameen, Ana Isabel Ramos-Lisbona, Lucy R Wedderburn, et al.
The Journal of Experimental Medicine|July 29, 2004
Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapyMichael R Ehrenstein, Jamie G Evans, Animesh Singh, et al.
Annals of the Rheumatic Diseases|April 7, 2007
B cell depletion therapy in systemic lupus erythematosus: long-term follow-up and predictors of responseKristine P Ng, Geraldine Cambridge, Maria J Leandro, et al.
Rheumatology (Oxford, England)|March 11, 2009
Use of a strategy based on calculated risk scores in managing cardiovascular risk factors in a large British cohort of patients with systemic lupus erythematosusSean G O'Neill, Jose M Pego-Reigosa, Aroon D Hingorani, et al.
Molecular Immunology|December 23, 2003
Somatic mutations to arginine residues affect the binding of human monoclonal antibodies to DNA, histones, SmD and Ro antigenJoanna Haley, Lesley J Mason, Sylvia Nagl, et al.
Pageof 28